Xu Ruosi, Chen Lu, Zhang Caiying, Li Huijuan
China Tropical Medicine.
Accepted: 2026-04-30
Abstract Objective: To investigate whether long non-coding RNA (LncRNA) nuclear-enriched abundant transcript 1 (NEAT1) promotes hepatic fibrosis in rats with non-alcoholic fatty liver disease (NAFLD) by modulating the microRNA-150-5p (miR-150-5p)/Notch receptor 2 (NOTCH2) axis. Methods: A NAFLD rat model was established by high-fat diet feeding, and the rats were divided into the model group, si-NC group, si-NEAT1 group, si-NEAT1+anti-NC group and si-NEAT1+anti-miR-150-5p group. Rats fed a normal diet were set as the control group, with 12 rats in each group. An automatic biochemical analyzer was used to detect the levels of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triacylglyceride (TG), aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Enzyme-linked immunosorbent assay (ELISA) was adopted to measure the levels of serum interferon-γ (IFN-γ) and interleukin-4 (IL-4). Hematoxylin-eosin (HE) staining was performed to observe the morphological structure of liver tissue. Masson staining was used to observe the liver tissue fibrosis. Immunohistochemistry was used to analyze the expression of α-smooth muscle actin (α-SMA) in liver tissue. Quantitative real-time polymerase chain reaction (qRT-PCR) was applied to detect the mRNA levels of NEAT1, miR-150-5p and NOTCH2 in liver tissue, and Western blot assay was applied to determine the protein expression of NOTCH2 in liver tissue. Moreover, dual-luciferase assay was conducted to verify the targeted regulatory relationships between NEAT1 and miR-150-5p, as well as between miR-150-5p and NOTCH2. Results Compared with the control group, the model group presented obvious structural damage of hepatic lobules, extensive hepatocellular steatosis and severe hepatic fibrosis. The levels of serum HDL-C and IFN-γ, and the level of miR-150-5p in liver tissue were lower, while the levels of LDL-C, TC, TG, AST, ALT, IL-4, the expressions of NEAT1, NOTCH2 mRNA and NOTCH2 protein, and the positive rate of α-SMA were higher (q = 36.159, 25.391, 17.323, 35.610, 39.287, 30.960, 22.244, 25.713, 27.043, 12.142, 14.532, 14.131, 29.102, P<0.05). Compared with the si-NC group, the si-NEAT1 group showed alleviated pathological damage and reduced hepatic fibrosis in liver tissue, the levels of serum HDL-C and IFN-γ, and the level of miR-150-5p in liver tissue were higher, while the levels of LDL-C, TC, TG, AST, ALT, IL-4, the expressions of NEAT1, NOTCH2 mRNA and NOTCH2 protein, and the positive rate of α-SMA were lower (q = 30.830, 18.550, 14.381, 29.938, 33.375, 24.808, 17.914, 22.907, 18.277, 10.957, 11.525, 11.747, 18.273, P<0.05). Compared with the si-NEAT1+anti-NC group, the si-NEAT1+anti-miR-150-5p group exhibited aggravated hepatic pathological damage and increased fibrosis degree, the levels of serum HDL-C and IFN-γ, and the level of miR-150-5p in liver tissue were lower, while the levels of LDL-C, TC, TG, AST, ALT, IL-4, the expressions of NOTCH2 mRNA and NOTCH2 protein, and the positive rate of α-SMA were higher (q = 24.360, 16.463, 11.439, 21.114, 27.710, 18.656, 13.950, 18.412, 15.857, 7.892, 9.875, 13.571, P<0.05), which indicated that down-regulation of miR-150-5p could reverse the ameliorative effect of the down-regulation of NEAT1 on the above indicators in NAFLD rats. Conclusion: Down-regulation of LncRNA NEAT1 can inhibit hepatic fibrosis in NAFLD rats by regulating the miR-150-5p/NOTCH2 axis.